Ads
related to: BioMarin Pharmaceutical
Search results
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the...
Simply Wall St. via Yahoo Finance· 2 days agoIt's easy to match the overall market return by buying an index fund. Active investors aim to buy...
Is BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Recent Stock Performance Influenced By Its...
Simply Wall St. via Yahoo Finance· 4 months agoBioMarin Pharmaceutical (NASDAQ:BMRN) has had a great run on the share market with its stock up by a...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript February 22, 2024...
Insider Sell: EVP, Chief Legal Officer George Davis Sells 13,764 Shares of Biomarin ...
GuruFocus.com via Yahoo Finance· 5 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and...
BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock Has Shown Weakness Lately But Financial Prospects...
Simply Wall St. via Yahoo Finance· 11 months agoIt is hard to get excited after looking at BioMarin Pharmaceutical's (NASDAQ:BMRN) recent...
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
GuruFocus.com via Yahoo Finance· 2 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and...
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
BioMarin Pharmaceutical Stock Sees IBD RS Rating Improve To 74
Investor's Business Daily· 1 year agoBioMarin Pharmaceutical stock had its Relative Strength (RS) Rating upgraded from 69 to 74 Tuesday...
BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This...
Simply Wall St. via Yahoo Finance· 1 month agoLast week, you might have seen that BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released its...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Looks Inexpensive But Perhaps Not Attractive Enough
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 8.8x BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) may be...
